Other than Eldorado's dilutive share issuance, and its mortgaging of a key asset, there's been no other news directly relevant to any of these companies today.I don't think so, and I'll tell you why not: The use of steroids to reduce inflammation caused by the novel coronavirus is a positive development, but it's a rather niche treatment of just one symptom of the disease -- not a cure-all, and certainly not a prophylactic against the virus.